Disease Burden Associated With All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization With Nirsevimab Against RSV-Related Outcomes

• 2024

  Log in to bookmark this resource.

  Log in
• Alexia Kieffer; Matthieu Beuvelet; Gerald Moncayo; Mersha Chetty; Aditya Sardesai; Robert Musci
PMID: 39235703DOI: https://dx.doi.org/10.1007/s40121-024-01037-7

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article discusses a study on the impact of using nirsevimab, a monoclonal antibody, to prevent RSV in infants during their first season in the UK. It highlights that universal immunization with nirsevimab could significantly reduce health and economic burdens compared to current practices. The study used models to predict outcomes like hospitalizations and costs saved. Nirsevimab showed promise in reducing RSV-related issues across different infant groups, including those born full-term or preterm. The findings suggest that widespread use of nirsevimab could benefit all infants by easing pressure on healthcare systems during peak seasons.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Cost-Benefit Analysis; Hospitalization; Immunization; Infant; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Diseases; United Kingdom; Health Care Costs; Immunization Programs; Palivizumab; Antibodies, Monoclonal, Humanized

Institutions: Sanofi

---

More like this

Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month 2024 · Brown University, Sanofi, University of Groningen, Merative Ethical Obligations Regarding Short-Term Global Health Clinical Experiences: An American College of Physicians Position Paper 2018 · Johns Hopkins University, National Center for Ethics in Health Care, U.S. Department of Veterans Affairs, University of California –San Diego School of Medicine, University of California, San Diego, Virginia Mason Medical Center Disaster Preparedness in Neonatal Intensive Care Units 2017 · American Academy of Pediatrics (AAP)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---